While immunogenic cell death is critical for the effectiveness of chemotherapy [106], the death of cancer cells also results in the release of ATP eventually being converted to immunosuppressive eADO within the TME following ectoenzymatic breakdown mediated by CD73 [87]. This evidence concerns the gene NT5E and cancer.